SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001437749-17-009875
Filing Date
2017-05-23
Accepted
2017-05-23 07:30:24
Documents
19
Period of Report
2017-05-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A kmph20170521_8ka.htm 8-K/A 35850
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 111061
3 EXHIBIT 99.2 ex99-2.htm EX-99.2 8509
4 slide14.jpg GRAPHIC 50041
5 slide13.jpg GRAPHIC 86116
6 slide12.jpg GRAPHIC 147565
7 slide11.jpg GRAPHIC 133043
8 slide10.jpg GRAPHIC 78308
9 slide9.jpg GRAPHIC 108177
10 slide8.jpg GRAPHIC 111248
11 slide7.jpg GRAPHIC 133280
12 slide6.jpg GRAPHIC 131862
13 slide5.jpg GRAPHIC 93641
14 slide4.jpg GRAPHIC 111910
15 slide3.jpg GRAPHIC 59740
16 slide2.jpg GRAPHIC 271954
17 slide1.jpg GRAPHIC 50041
18 ex99-1img002.jpg GRAPHIC 3740
19 ex99-1img001.jpg GRAPHIC 2054
  Complete submission text file 0001437749-17-009875.txt   2324258
Mailing Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241
Business Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36913 | Film No.: 17862666
SIC: 2834 Pharmaceutical Preparations